KCS Wealth Advisory’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $775K | Buy |
21,391
+314
| +1% | +$11.4K | 0.33% | 74 |
|
|
2023
Q2 | $751K | Buy |
21,077
+862
| +4% | +$30.7K | 0.26% | 88 |
|
|
2023
Q1 | $719K | Buy |
20,215
+2,004
| +11% | +$71.3K | 0.27% | 88 |
|
|
2022
Q4 | $640K | Sell |
18,211
-5,795
| -24% | -$204K | 0.27% | 87 |
|
|
2022
Q3 | $706K | Buy |
24,006
+1,799
| +8% | +$52.9K | 0.33% | 85 |
|
|
2022
Q2 | $1.21M | Buy |
22,207
+270
| +1% | +$14.7K | 0.54% | 67 |
|
|
2022
Q1 | $1.19M | Buy |
21,937
+1,032
| +5% | +$56.2K | 0.55% | 65 |
|
|
2021
Q4 | $1.15M | Buy |
20,905
+1,115
| +6% | +$61.4K | 0.46% | 73 |
|
|
2021
Q3 | $945K | Buy |
19,790
+133
| +0.7% | +$6.35K | 0.45% | 77 |
|
|
2021
Q2 | $978K | Buy |
19,657
+943
| +5% | +$46.9K | 0.46% | 76 |
|
|
2021
Q1 | $835K | Buy |
18,714
+925
| +5% | +$41.3K | 0.43% | 79 |
|
|
2020
Q4 | $818K | Sell |
17,789
-5,229
| -23% | -$240K | 0.54% | 72 |
|
|
2020
Q3 | $1.08M | Sell |
23,018
-698
| -3% | -$32.8K | 0.86% | 41 |
|
|
2020
Q2 | $1.21M | Buy |
23,716
+516
| +2% | +$26.3K | 1% | 31 |
|
|
2020
Q1 | $1.1M | Buy |
23,200
+1,327
| +6% | +$62.9K | 1.12% | 25 |
|
|
2019
Q4 | $1.29M | Buy |
21,873
+283
| +1% | +$16.6K | 0.96% | 31 |
|
|
2019
Q3 | $1.15M | Buy |
21,590
+684
| +3% | +$36.5K | 0.8% | 37 |
|
|
2019
Q2 | $1.05M | Buy |
20,906
+873
| +4% | +$43.7K | 0.83% | 41 |
|
|
2019
Q1 | $1.05M | Buy |
20,033
+2,091
| +12% | +$109K | 0.91% | 33 |
|
|
2018
Q4 | $857K | Buy |
17,942
+1,607
| +10% | +$76.8K | 0.9% | 38 |
|
|
2018
Q3 | $820K | Buy |
16,335
+2,268
| +16% | +$114K | 0.76% | 46 |
|
|
2018
Q2 | $709K | Buy |
14,067
+557
| +4% | +$28.1K | 0.66% | 60 |
|
|
2018
Q1 | $660K | Buy |
13,510
+3,103
| +30% | +$152K | 0.6% | 63 |
|
|
2017
Q4 | $461K | Buy |
+10,407
| New | +$461K | 0.45% | 87 |
|